We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
salesforce (CRM) Q4 Earnings Top Estimates, Q1 View Upsets
Read MoreHide Full Article
salesforce.com Inc. (CRM - Free Report) delivered impressive fourth-quarter fiscal 2019 non-GAAP earnings of 70 cents per share, comprehensively exceeding the Zacks Consensus Estimate of 56 cents and also the year-ago quarter’s figure of 47 cents.
Revenues of $3.60 billion increased 26% year over year and also surpassed the Zacks Consensus Estimate of $3.56 billion. Moreover, the top line improved 27% at constant currency (cc). Excluding the acquisition of Mulesoft, the same grew 20%. Notably, MuleSoft contributed $181 million to revenues in the fourth quarter.
Additionally, the rapid adoption of the company’s cloud-based solutions led to better-than-expected results. However, unfavorable foreign exchange volatility persists to be an overhang.
Although fourth-quarter 2019 EPS and revenues beat consensus estimates, the stock still declined following the earnings release as guidance for first-quarter fiscal 2020 disappointed. Management projected a revenue range of $3.67-$3.68 billion, lower than the Zacks Consensus Estimate of $3.72 billion.
Further, for the fiscal first quarter non-GAAP earnings are estimated in the range of 60-61 cents per share while the Zacks Consensus Estimate is pegged at 62 cents.
However, the company’s strong guidance for fiscal 2020 is a positive. Further, the company is now aiming to achieve revenues of $26-$28 billion by fiscal 2023.
Quarter in Detail
Coming to its business segments, revenues at Subscription and Support (94% of total) rose about 26% from the year-earlier period to $3.68 billion. Professional Services and Other revenues (6%) climbed 16% to $228 million.
Sales Cloud revenues ascended 11% year over year to $1.05 billion. Revenues from Service Cloud, one of the company’s largest and fastest-growing businesses, augmented 22% to $964 million. Marketing & Commerce Cloud surged 34% to $535 million.
salesforce’s Platform and other revenues soared 54% to $825 million. Excluding Mulesoft’s subscription and support revenues of $156 million, the segment grew 25%.
Geographically, the company witnessed revenue growth of 26%, each in the Americas and Asia Pacific and 31% in Europe on a year-over-year basis. The company continues to win customers in the international market and also strengthened its relationships with some of the leading companies in the world, which in turn, is helping it deliver strong growth internationally.
On the earnings call, management noted that 42% of its new hires in the fiscal fourth quarter was outside the Americas. Further, its total number of global partner certifications grew 41% year over year.
salesforce.com, inc. Price, Consensus and EPS Surprise
salesforce’s non-GAAP gross profit came in at $2.76 billion, up 25.6% from the prior-year quarter. Gross margin contracted 20 basis points (bps) to 76.6%.
Non-GAAP operating expenses escalated 28.8% year over year to $2.17 billion. As a percentage of revenues, operating expenses rose 140 bps to 60.1%.
salesforce posted non-GAAP operating income of $596 million, up 15% year over year. However, operating margin contracted 158 bps to 16.5% due to higher operating expenses as a percentage of revenues.
Balance Sheet & Cash Flow
salesforce exited the reported quarter with cash, cash equivalents and marketable securities of $4.34 billion compared with $3.45 billion in the fiscal third quarter.
As of Jan 31, 2019, total unearned revenues were $8.56 billion, up 22% on a year-over-year basis. The metric increased 24% at CC.
salesforce generated operating cash flow of $1.33 billion and free cash flow of $1.16 billion.
Guidance
For fiscal 2020, revenues are predicted between $15.95 billion and $16.05 billion, marking 20-21% growth year over year compared with the previous anticipation of $15.90-$16 billion.
Non-GAAP earnings are envisioned in the range of $2.74-$2.76. The Zacks Consensus Estimate stands at $2.73.
Operating cash flow is forecast to increase 20-21% year over year.
Long-term earnings growth rate for CommVault, eGain and Fortinet is projected at 15.8%, 30%, 12% and 16.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
salesforce (CRM) Q4 Earnings Top Estimates, Q1 View Upsets
salesforce.com Inc. (CRM - Free Report) delivered impressive fourth-quarter fiscal 2019 non-GAAP earnings of 70 cents per share, comprehensively exceeding the Zacks Consensus Estimate of 56 cents and also the year-ago quarter’s figure of 47 cents.
Revenues of $3.60 billion increased 26% year over year and also surpassed the Zacks Consensus Estimate of $3.56 billion. Moreover, the top line improved 27% at constant currency (cc). Excluding the acquisition of Mulesoft, the same grew 20%. Notably, MuleSoft contributed $181 million to revenues in the fourth quarter.
Additionally, the rapid adoption of the company’s cloud-based solutions led to better-than-expected results. However, unfavorable foreign exchange volatility persists to be an overhang.
Although fourth-quarter 2019 EPS and revenues beat consensus estimates, the stock still declined following the earnings release as guidance for first-quarter fiscal 2020 disappointed. Management projected a revenue range of $3.67-$3.68 billion, lower than the Zacks Consensus Estimate of $3.72 billion.
Further, for the fiscal first quarter non-GAAP earnings are estimated in the range of 60-61 cents per share while the Zacks Consensus Estimate is pegged at 62 cents.
However, the company’s strong guidance for fiscal 2020 is a positive. Further, the company is now aiming to achieve revenues of $26-$28 billion by fiscal 2023.
Quarter in Detail
Coming to its business segments, revenues at Subscription and Support (94% of total) rose about 26% from the year-earlier period to $3.68 billion. Professional Services and Other revenues (6%) climbed 16% to $228 million.
Sales Cloud revenues ascended 11% year over year to $1.05 billion. Revenues from Service Cloud, one of the company’s largest and fastest-growing businesses, augmented 22% to $964 million. Marketing & Commerce Cloud surged 34% to $535 million.
salesforce’s Platform and other revenues soared 54% to $825 million. Excluding Mulesoft’s subscription and support revenues of $156 million, the segment grew 25%.
Geographically, the company witnessed revenue growth of 26%, each in the Americas and Asia Pacific and 31% in Europe on a year-over-year basis. The company continues to win customers in the international market and also strengthened its relationships with some of the leading companies in the world, which in turn, is helping it deliver strong growth internationally.
On the earnings call, management noted that 42% of its new hires in the fiscal fourth quarter was outside the Americas. Further, its total number of global partner certifications grew 41% year over year.
salesforce.com, inc. Price, Consensus and EPS Surprise
salesforce.com, inc. Price, Consensus and EPS Surprise | salesforce.com, inc. Quote
Operating Details
salesforce’s non-GAAP gross profit came in at $2.76 billion, up 25.6% from the prior-year quarter. Gross margin contracted 20 basis points (bps) to 76.6%.
Non-GAAP operating expenses escalated 28.8% year over year to $2.17 billion. As a percentage of revenues, operating expenses rose 140 bps to 60.1%.
salesforce posted non-GAAP operating income of $596 million, up 15% year over year. However, operating margin contracted 158 bps to 16.5% due to higher operating expenses as a percentage of revenues.
Balance Sheet & Cash Flow
salesforce exited the reported quarter with cash, cash equivalents and marketable securities of $4.34 billion compared with $3.45 billion in the fiscal third quarter.
As of Jan 31, 2019, total unearned revenues were $8.56 billion, up 22% on a year-over-year basis. The metric increased 24% at CC.
salesforce generated operating cash flow of $1.33 billion and free cash flow of $1.16 billion.
Guidance
For fiscal 2020, revenues are predicted between $15.95 billion and $16.05 billion, marking 20-21% growth year over year compared with the previous anticipation of $15.90-$16 billion.
Non-GAAP earnings are envisioned in the range of $2.74-$2.76. The Zacks Consensus Estimate stands at $2.73.
Operating cash flow is forecast to increase 20-21% year over year.
Zacks Rank & Other Stocks to Consider
salesforce currently sports a Zacks Rank #1 (Strong Buy). A few other stocks worth considering in the broader technology sector are CommVault Systems, Inc. (CVLT - Free Report) , eGain Corporation (EGAN - Free Report) and Fortinet Inc. (FTNT - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for CommVault, eGain and Fortinet is projected at 15.8%, 30%, 12% and 16.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>